Olopatadine eye drops recalled after unspecified impurity exceeded specification limit
USV Private Limited is recalling 8,952 bottles of Olopatadine Hydrochloride Ophthalmic Solution USP 0.1% after an unspecified impurity exceeded the specification limit.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: Scored 2 as a specification failure: the record cites an unspecified impurity above limit without naming it, describing a health consequence, or reporting injury.
Plain-English summary
Olopatadine Hydrochloride Ophthalmic Solution USP 0.1%, in 5 mL bottles, manufactured for Sola Pharmaceuticals of Baton Rouge, Louisiana, is being recalled for failed impurities and degradation specifications. The result for any individual unspecified impurity exceeds the specification limit.
The recall covers 8,952 bottles from lot 35000409, expiring January 2026, carrying NDC 70512-0520-05. The product was distributed nationwide in the United States. The FDA has classified the recall as Class II.
The enforcement record states the specification failure without naming the impurity or describing a health consequence, and reports no injuries.
Patients holding the affected lot should contact their pharmacy or prescriber about a replacement.
The recalled product
- Product
- Olopatadine Hydrochloride Ophthalmic Solution USP 0.1 %, 5 mL (0.17 FL OZ) bottles, Manufactured for: SOLA PHARMACEUTICALS LLC, Baton Rouge, LA 70810, NDC 70512-0520-05
- Manufacturer
- USV Private Limited
- Category
- Drug — Ophthalmic solution
- Hazard
- impurity
- out-of-specification
- degradation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 35000409
- Exp. Date 01/2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22